-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Carisma Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
- Carisma Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$11.2M, a 43.8% increase year-over-year.
- Carisma Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$72.5M, a 8.9% increase year-over-year.
- Carisma Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$86.9M, a 41.9% decline from 2022.
- Carisma Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$61.2M, a 18122% decline from 2021.
- Carisma Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$336K, a 98.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)